BiotechTube
Home/Intus Biosciences/Paul Denslow
PD

Paul Denslow

CEO & Co-Founder

Intus Biosciences

Therapeutic Areas

OncologyGastrointestinalChronic Disease

Intus Biosciences Pipeline

DrugIndicationPhase
Research CollaborationsVarious (e.g., early bowel polyps, necrotizing enterocolitis)Research
GutID™Gut health optimization & personalized insightsCommercial
Biomarker Discovery PlatformCancer & chronic disease diagnosticsDiscovery/Research

Leadership Team at Intus Biosciences

MD
Mark Driscoll, PhD
CSO & Co-Founder
DF
Daniel Fasulo, PhD
Head of Bioinformatics & IT
SK
Soo-Young Kang, PhD
Head of Product
PL
Peter Lee, JD
Head of Corporate Strategy
View full Intus Biosciences profile